Ex-UChicago Prof Admits Trading On Inside Drug Trial Info
A former University of Chicago professor admitted in federal court Monday that he traded Five Prime Therapeutics Inc. stock based on inside information about positive trial results for bemarituzumab, the company's...To view the full article, register now.
Already a subscriber? Click here to view full article